Can doctor report cards boost care for millions with hypertension and diabetes?

NCT ID NCT07542587

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving primary care doctors detailed feedback on how well they follow treatment guidelines can improve care for patients with high blood pressure and type 2 diabetes. Researchers will enroll 324 healthcare providers in Nepal, Mozambique, Tanzania, and China. Half will receive the feedback intervention, and half will not. The study uses 'secret shoppers' (trained actors) to measure how well doctors diagnose and treat these conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

audit and feedback (a process where healthcare providers receive structured reports on their performance against guidelines)

What this could lead to

If successful, this could show a simple, low-cost way to improve how primary care doctors manage hypertension and diabetes in developing countries.

What could go wrong

This is an early-stage implementation study, not a drug trial. The effect may be small or vary across countries, and it does not directly test a new treatment for patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus hypertensive disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.